A Phase I Open Label Dose Escalation Study for the Safety and Tolerability of AZD2171 in Solid Tumors in Japan

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
A Phase I open label dose escalation study to assess the safety and tolerability of AZD2171 following single and multiple oral doses in patients in Japan with advanced solid malignancies. In addition there will be an expanded cohort multi-centre study phase with NSCLC patient and CRC patients
Epistemonikos ID: c6648219229fac8ae07ae0107959e775db48cc02
First added on: May 04, 2024